| Literature DB >> 24011377 |
Paul D Gardner1, Jonathan P Eshbaugh, Shannon D Harpest, Aaron W Richardson, Kent C Hofacre.
Abstract
The growing threat of an influenza pandemic presents a unique challenge to healthcare workers, emergency responders, and the civilian population. The Occupational Safety and Health Administration (OSHA) recommends National Institute for Occupational Safety and Health (NIOSH)-approved respirators to provide protection against infectious airborne viruses in various workplace settings. The filtration efficiency of selected NIOSH-approved particulate N95 and P100 filtering facepiece respirators (FFRs) and filter cartridges was investigated against the viable MS2 virus, a non-pathogenic bacteriophage, aerosolized from a liquid suspension. Tests were performed under two cyclic flow conditions (minute volumes of 85 and 135 L/min) and two constant flow rates (85 and 270 L/min). The mean penetrations of viable MS2 through the N95 and P100 FFRs/cartridges were typically less than 2 and 0.03%, respectively, under all flow conditions. All N95 and P100 FFR and cartridge models assessed in this study, therefore, met or exceeded their respective efficiency ratings of 95 and 99.97% against the viable MS2 test aerosol, even under the very high flow conditions. These NIOSH-approved FFRs and particulate respirators equipped with these cartridges can be anticipated to achieve expected levels of protection (consistent with their assigned protection factor) against airborne viral agents, provided that they are properly selected, fitted, worn, and maintained.Entities:
Mesh:
Year: 2013 PMID: 24011377 PMCID: PMC7196694 DOI: 10.1080/15459624.2013.818228
Source DB: PubMed Journal: J Occup Environ Hyg ISSN: 1545-9624 Impact factor: 2.155
Summary of Cartridges and FFRs
| Filter Type | Rating | Model | Manufacturer |
|---|---|---|---|
| Cartridge | N95 | Flexi-Filter | MSA (Pittsburgh, Pa.) |
| N95 | 7506 | North Safety Products (Cranston, R.I.) | |
| P100 | HE-T | SEA (Branford, Conn.) | |
| P100 | 1050 | Survivair (Santa Ana, Calif.) | |
| FFR | N95 | 1730 | Louis M. Gerson, Co., Inc. (Middleboro, Mass.) |
| N95 | Affinity Plus | MSA (Pittsburgh, Pa.) | |
| P100 | 8293 | 3M (St. Paul, Minn.) | |
| P100 | 2360 | Moldex-Metric, Inc. (Culver City, Calif.) |
FIGURE 1.Schematic of test system used to measure viable viral penetration
FIGURE 2.Viable MS2 virus size distribution
Comparison of Percent Penetration Measured Using MS2 Aerosol Challenge and Bioassay Method under Constant and Cyclic Flow Conditions
| Flow Rate | |||||
|---|---|---|---|---|---|
| Constant | Cyclic | ||||
| Filter Type | Filter | 85 | 270 | 85 | 135 |
| Average Penetration (%) | |||||
| Cartridge | MSA N95 | 0.55 ± 0.75 | 1.3 ± 1.2 | 1.1 ± 1.0 | 0.54 ± 0.36 |
| North N95 | 0.30 ± 0.10 | 1.9 ± 1.1 | 1.7 ± 2.0 | 2.5 ± 1.7 | |
| Survivair P100 | 0.022 ± 0.015 | <0.018 | <0.012 | <0.030 | |
| SEA P100 | <0.002 | <0.009 | <0.007 | <0.015 | |
| FFR | MSA N95 | 0.51 ± 0.37 | 1.7 ± 1.8 | 0.93 ± 0.60 | 1.1 ± 0.61 |
| Gerson N95 | 0.51 ± 0.30 | 1.8 ± 0.55 | 0.48 ± 0.07 | 0.89 ± 0.43 | |
| 3M P100 | <0.001 | <0.014 | <0.002 | <0.003 | |
| Moldex P100 | 0.005 ± 0.003 | 0.050 ± 0.007 | <0.001 | 0.010 ± 0.006 | |
Single cartridge testing performed at half the flow rate since filters are worn in pairs.
At least one trial resulted in penetration below detectable limit.
FIGURE 3.Comparison of 50 nm (MPPS) inert aerosol and viable viral aerosol (MMAD of ∼ 500 nm) penetration of cartridge filters at constant and cyclic flow rates
FIGURE 4.Comparison of 50 nm (MPPS) inert aerosol and viable viral aerosol (MMAD of ∼ 500 nm) penetration of FFRs at constant and cyclic flow rates